Rocket Companies Announces First Quarter 2025 Results
Generated Q1’25 total revenue, net of $1.0 billion and adjusted revenue of $1.3 billion. Adjusted revenue came in at the high end of our guidance range Reported... Read more.
Spyre Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
On track for mid-year initiations of planned Phase 2 studies in ulcerative colitis (“UC”) and rheumatoid arthritis (“RA”), providing for... Read more.
OneStream Announces First Quarter 2025 Financial Results
BIRMINGHAM, Mich., May 8, 2025 /PRNewswire/ — OneStream, Inc. (Nasdaq: OS), the leading enterprise Finance management platform that modernizes the Office of... Read more.
Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights
MORRISTOWN, N.J., May 8, 2025 /PRNewswire/ — Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to... Read more.
Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights
– BEACH301 study of TYRA-300 for Pediatric Achondroplasia (ACH) Open for Enrollment – – Initiated patient dosing in SURF431 study of TYRA-430 for... Read more.
TransMedics Reports First Quarter 2025 Financial Results
ANDOVER, Mass., May 8, 2025 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming... Read more.
Cars.com to Participate in Upcoming Investor Conference
CHICAGO, May 8, 2025 /PRNewswire/ — Cars.com Inc. (NYSE: CARS) (d/b/a “Cars Commerce Inc” or the “Company”), an audience-driven technology... Read more.
CleanSpark Reports Second Quarter Fiscal 2025 Results
$181.7M quarterly revenue, up 62.5% from prior year Bitcoin production grew to 1,957, with an average revenue per coin of $92,811 LAS VEGAS, May 8, 2025 /PRNewswire/... Read more.
Theravance Biopharma, Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
YUPELRI® (revefenacin) net sales of $58.3 million, recognized by Viatris, increased 6% versus Q1 20241 TRELEGY net sales of $854M, as reported by GSK, increased... Read more.
Quantum Computing, Inc. Announces Key Leadership Promotions to Support Growth Strategy
Milan Begliarbekov promoted to Chief Operating Officer; Pouya Dianat promoted to Chief Revenue Officer HOBOKEN, N.J., May 8, 2025 /PRNewswire/ — Quantum Computing... Read more.